Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


Drug Discovery India 2013

27 Sep 2013 - 28 Sep 2013 - Banglore, India



Bookmark and Share


The Pharmaceutical industry is utilizing a plethora of novel approaches, techniques and technologies for Drug Design and Discovery. Use of novel interdisciplinary approaches, developed by understanding integrated biological systems and processes at the functional and molecular levels, has made the discovery process more rational, but complex too. Therefore for optimizing the discovery and development of new molecular entities it is a current practice to follow collaborative research amongst interdisciplinary academic/research centers, government agencies and pharmaceutical industry.


With Dr. Rathnam Chatgutru, (Senior Director, SRI International, USA) serving as Chairperson, Drug Discovery India 2013, will provide an unprecedented opportunity  to explore the contract research and collaborative options amongst various research fraternities. Planned open panel discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the drug discovery landscape, especially in the Indian context, and offer ways and means to de-risk the patent cliff experienced by the pharmaceutical industry in recent years.


The conference will be co-located with Genomic & Proteomics Research and Microfluidics & Lab-on-a-Chip meetings will be held at Sheraton Hotel at Brigade Gateway, Bangalore, India. Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.


Running alongside the Drug Discovery India 2013 conference will be an Exhibition covering the latest technological advances and associated services within these fields. We look forward to welcoming you at the Drug Discovery India 2013 Conference and Exhibition and hope that the two days will be both informative and enjoyable.



Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!